2023 Moores Annual Scientific Retreat |
November 14, 2023 | Scripps Seaside Forum |
This year’s program will include a special presentation by Dr. John Carethers, Distinguished Professor of Medicine and Vice Chancellor for Health Sciences, a keynote address by Dr. Cheryl Anderson, Professor and Dean of the Herbert Wertheim School of Public Health and Human Longevity Science.
|
California is One Step Closer to Equitable Cancer Care with New Biomarker Testing Law |
On October 7, 2023, Governor Newsom signed into law Senate Bill 496: Biomarker Testing. Authored by California State Senator Monique Limón, the new law will require Medi-Cal and private insurers to cover medically necessary biomarker testing, which will allow better access to effective, individualized cancer treatments. The bill was co-sponsored by the American Cancer Society Cancer Action Network and the University of California, with expert input from the University of California Cancer Consortium.
|
New Cancer Therapy Target Stops Tumor Cells From Sharing Resources |
In a study led by Moores Member Gen-Sheng Feng, Ph.D., researchers at UC San Diego have discovered a process by which liver cells share molecules to multiply in unfavorable conditions, which has revealed a strategy that tumors use to evade therapy.
|
AACR Annual Meeting 2024: Submit an Abstract |
April 5–10, 2024 | San Diego Convention Center
|
Two weeks remain to submit your abstracts for presentation at the 2024 AACR Annual Meeting. Oral and poster presentations selected from proffered abstracts are essential to the AACR Annual Meeting program. Every proffered abstract that is accepted for publication in the Proceedings of the AACR is scheduled for presentation at the meeting, and all abstracts are considered for oral presentation in minisymposia.
|
|
|
November 8, 2023 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
November 8, 2023 | 12:00 p.m. to 1:00 p.m.
Comer Commons
|
November 9, 2023 | 9:00 a.m. to 1:00 p.m.
Moores 2nd Floor
|
November 13, 2023 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
|
|
Updates in Multidisciplinary Management of Lung Cancer |
Wednesday, November 8, 2023 | 5:30 p.m. to 6:30 p.m.
|
The Oncology Live CME series features engaging, live presentations that provide updates in the multidisciplinary management of lung cancer. This presentation features experts Lyudmila A. Bazhenova, M.D., Mark W. Onaitis, M.D., and James Urbanic, M.D. Register Now
|
Institutional Perspectives in Cancer: Lung Cancer |
Wednesday, November 15, 2023 | 6:00 p.m. to 7:40 p.m.
|
This OncLive IPC event will address lung cancer and feature Moores experts Dr. Lyudmila A. Bazhenova, Dr. Karen Yun, Dr. Sandip P. Patel, and Dr. Kathryn A. Gold. Register now to reserve your seat.
|
NCI Intramural Continuing Umbrella of Research Experiences (iCURE) |
iCURE recruits cohorts of students and scientists from diverse backgrounds into the multidisciplinary environment of NCI and supports their mentored research experiences. The program provides 2-year awards for postbaccalaureate individuals and graduate students and 3-year awards for postdoctoral fellows. Learn More and Apply
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Robert A. Winn Diversity in Clinical Trials Career Development Award (CDA) Live Q&A Sessions |
November 9 and December 8, 2023 |
Damon Runyon Clinical Investigator Award |
This award provides outstanding young physicians with the resources and training essential to becoming successful clinical investigators, with the purpose of increasing the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments. Award funds can be used for a variety of scientific needs, with include (1) a stipend and/or fringe benefits for the applicant, (2) salaries for professional and technical personnel, and (3) special equipment, supplies, and miscellaneous items required to conduct the proposed research. Deadline: November 14, 2023 at 5:00 p.m. PT
|
Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed) |
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for HTA Research Centers, one of the three scientific components of the NCI Human Tumor Atlas Network (HTAN). Each HTA Research Center will construct one human precancer or advanced cancer atlas, with an explicit focus on how evolving spatial relationships contribute to important transitions in cancer from tumor initiation to metastasis. Deadline: December 5, 2023
|
Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed) |
This NOFO solicits applications for PCA Research Centers, one of the three scientific components of the NCI HTAN. Each PCA Research Center will construct one 3D precancer atlas that comprehensively characterizes a pre-malignant lesion with an explicit focus on understanding the transition from a precancerous lesion to malignancy. Deadline: December 5, 2023
|
|
|
| High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma |
Alfredo A. Molinolo, M.D., Ph.D. (Solid Tumor Therapeutics), Jing Yang, Ph.D. (Cancer Biology and Signaling), and J. Silvio Gutkind, Ph.D. (Cancer Biology and Signaling)
|
|
|
| Human microglia maturation is underpinned by specific gene regulatory networks |
Louise C. Laurent, M.D., Ph.D., Christopher K. Glass, M.D., Ph.D. (Cancer Biology and Signaling), and Nicole Coufal, M.D., Ph.D. (Structural and Functional Genomics)
|
|
|
| Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes |
Shankar Subramaniam, Ph.D. (Structural and Functional Genomics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
NRG-GY022: Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin |
PI: Jyoti Mayadev, M.D.
NCT: NCT03997370
|
EA8212: A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Nave High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE) |
PI: Aditya Bagrodia, M.D., FACS
NCT: NCT05538663
|
M-2018-344: A Multicenter Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing AntiCD20 and AntiCD19 Specific Chimeric Antigen Receptor in Subjects with Relapsed and/or Refractory Diffuse Large B-cell Lymphoma |
PI: Dimitrios Tzachanis, M.D., Ph.D.
NCT: NCT04792489
|
BR-003: Prospective, Multicenter Confirmatory Clinical Evaluation of Novilase Interstitial Laser Therapy for the Focal Destruction of Malignant Breast Tumors 15 mm |
PI: Haydee Ojeda-Fournier, M.D.
NCT: NCT03463954
|
TRANSFORMATION INITIATIVE |
-
CTO is actively recruiting 11 roles (over 55 open positions), and a new Training and Education Specialist role will be posted soon. You are encouraged to review these positions and apply to any that align with your unique skillsets and interests.
-
Fifty-one trials have entered Fast Lane, 14 of which have been activated to date across the Lung, Breast, GU, Gyn, H&N, BMT, Skin and ET disease teams. Kudos to the cross-functional teams across UCSD for their outstanding efforts to prioritize these high-priority trials for Moores patients.
-
CTO has completed the retrospective review of over 150 PRMS Balanced Scorecard responses across all Disease Teams. CTO continues to advance process improvement opportunities, which include the development of a Clinical Trial Budgeting SOP. Thanks to the members of the Business and Finance Process Workstreams for their continued support of these initiatives.
-
The Data/Technology Workstream is implementing functionality in Epic to automatically notify CRCs of procedure results linked to their research study(ies). Coordinators should monitor their Epic InBasket ‘CC’d Results’ tab for their patients’ procedure results. Thanks to the Epic Research team for its support of CTO initiatives.
-
Keep the feedback coming! You are encouraged to continue woking with your managers and sharing your feedback, as it informs future communications and upcoming Town Hall topics.
|
|
|
EQUITY, DIVERSITY, AND INCLUSION (EDI) |
November is Native American Heritage Month |
Moores is proud to celebrate its unique culture by recognizing November as Native American Heritage Month, in alignment with a draft statement by the UCSD Intertribal Resource Center:
The UC San Diego community holds great respect for the land and the original people of the area where our campus is located. The university is built on the un-ceded territory of the Kumeyaay Nation. Today, the Kumeyaay people continue to maintain their political sovereignty and cultural traditions as vital members of the San Diego community. We acknowledge their tremendous contributions to our region and thank them for their stewardship.
The Intertribal Resource Center is working with Kumeyaay community members and the campus community to create an official statement for UC San Diego. Please visit https://itrc.ucsd.edu/ for more information and resources to help Moores celebrate you.
Moores Members are encouraged to contact EDI to recognize Native staff, researchers, faculty, or trainees (students) who have contributed to the community. Please share your nominees' names, email, and two to three sentences about their contribution to Moores, patient care, and/or research at mcc_edi@health.ucsd.edu.
|
New Moores Associate Director for EDI, Dr. Melody Schiaffino, and members of her EDI team hosted a celebration for Dia de los Muertos (Day of the Dead) on Wednesday, November 1, 2023. Nearly 300 MCC Members were in attendance to take part in Pan Dulce (light breakfast), Cafecito (coffee), and a screening of Disney’s Coco. The EDI team was overjoyed by the participation and response to this cultural initiative that served as a catalyst for conversation around the Moores EDI program.
Our team was approached with so much gratitude and positive feedback throughout the day. We are so excited to continue our work to celebrate, support, and work together to build a culture of belonging at Moores. We had so many different units and roles represented, I look forward to keeping that momentum going.
–Melody Schiaffino, Ph.D., M.P.H.
About Dia de los Muertos
|
- Día de los Muertos was declared a World Heritage Festival by UNESCO in 2008.
- It is an indigenous celebration from Mexico.
- It is celebrated November 1 and 2 with an ofrenda (altar), food, and family. Often costumes (Catrinas) and masked parades occur in many cities in Mexico and globally.
- The ofrenda (altar), core of the celebration, are colorful tables decorated with candles, food, photographs, papel picado, and other items that celebrate ancestors.
- Other staples for the altar are cempasúchil (marigolds) and Pan de Muertos.
|
Holidays to celebrate ancestors or departed loved ones can be found around the world! Is there a celebration we should include going forward? Let the EDI team know how they can improve as it grows and learns at mcc_edi@health.ucsd.edu.
|
NCI Embracing the Complexity: Transdisciplinary Approaches to Advance the Science of Health Disparities Ideation Minilabs |
In these participatory virtual minilabs, participants will build on the foundation of what a future in health disparities research should look like and take a deeper dive into what it will take to get there. Learn More and Apply
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
|
|
|
The Science Of . . . Cancer Prevention and Health Literacy |
In the latest episode of The Science Of . . ., student hosts Jeremiah Bosley, Alivia Rollan, and Haydee Arancibia-Hardwick, sat down to discuss the science of cancer prevention and health literacy with Dr. Jesse Nodora, Associate Professor, Radiation Medicine and Applied Sciences at UC San Diego Health and Community Engagement lead for COE at Moores.
|
|
|
Listen to Dr. Nodora's unique story, journey, and perspectives on cancer, health literacy, and health promotion through the engaging conversation, "Rapid Fire" questions, and live audience participation.
Listen Now
|
HPV Cancer Survivors Connect: Expert Hour |
November 9, 2023 | 4:00 p.m. to 5:00 p.m. |
COE will present as part of HPV Cancer Survivors Connect: Expert Hour. Join this 1-hour virtual gathering of experts to share their insights and experiences to bridge gaps and foster a supportive community for HPV cancer survivors. Do not miss this opportunity to connect, learn, and be inspired, along with the following experts:
|
- Julia Brown, M.P.H., Program Manager for the HPV Cancer Prevention Program at St. Jude Children’s Research Hospital
-
Margaux Stack-Babich, M.P.H., Moores COE Manager, UC San Diego Health
|
Breast Cancer in the Hispanic/Latine Community |
November 9, 2023 | 6:00 to 7:00 p.m. |
Join COE at the Borderview YMCA (3601 Arey Dr., San Diego, CA 92154) for a free workshop on preventing breast cancer in the Hispanic/Latine community. This event on breast cancer in the community is open to all and will inform about the signs and symptoms of breast cancer, its impact on the Hispanic/Latine community, and the important steps that be taken today to prioritize health. Do not miss out on this valuable opportunity to engage with experts, share insights and strengthen our collective knowledge. Mark your calendars and be part of this vital conversation about well-being. No registration required. Spanish translator available.
View Flyer
|
South County Action Network Community Resource Fair: Redefining Quality of Life & Longevity |
November 16, 2023 | 9:00 a.m. to 12:00 p.m. |
On November 16, COE will table at the South County Action Network, Redefining Quality of Life & Longevity Event, a free community health and resource fair. The event will take place at St. Paul’s Plaza (1420 E. Palomar St., Chula Vista, CA 91913) and feature free presentations on dementia, community resources, raffle drawings, snacks, and more.
Register Now
|
|
|
|
